How to Critically Appraise a Trial in 10 Minutes: The NERDCAT Approach: The Tweetorial 1/

CPR in a Vfib arrest debrillated to NSR seen by TEE #echofirst via @DrECMO

Comparison of Quadruple Therapy Sequencing Strategies for Heart Failure With Reduced Ejection Fraction | Journal of the American Heart Association

Network Meta-Analysis of Quality of Life in Heart Failure With Reduced Ejection Fraction @NSepehrvand @Ricky_Turgeon @justinezekowitz @CVC_UAlberta #AHAJournals https://t.co/AdqdyQ04DT

I was honored to co-lead this effort with Alex Chan and a wonderful groups of authors. Give it a read. @UConnPharmacy

@djc795 @DFCapodanno @TCTMD @PCRonline Attributes of ideal NI trial: 90-95% power Margin fixed as relative difference, RR 1.5-1.2 Separate assessment of efficacy & safety Criterion for win: NI efficacy, superior safety NI met with ITT & PP analysis How many NI trials, especially monotherapy vs DAPT trials, meet these?

Is there finally a verdict on MRAs in HFmrEF/HFpEF? This recent #JCFIgnite! re-examines the data and finds that both steroidal and non-steroidal MRAs may be beneficial 💪 🔗 https://t.co/gCOzLkXlix

We are inviting you to join CSHP and the Canadian Cardiovascular Pharmacists Network this Saturday February 1, 2025 at 10:00 AM EST (or 7:00 AM PST) for a virtual event on an all things related to Atherosclerotic Cardiovascular Disease. More details: https://t.co/w6ys3NVDM7

Sodium restrictions in heart failure

Join me at the 2nd @CCPNRx @CSHP_SCPH CVD Symposium--focusing on ASCVD--on Feb 1 (to kick off Heart Month). The program is virtual (and will also be available to view after the event) and fully accredited. #pharmacy #CVD

Evaluation of PHARM-HF, a pharmacist-led heart failure medication titration clinic: A pre-post study Uptake of GDMT significantly increased from admission to discharge from the PHARM-HF medication optimization clinic https://t.co/tXGWxBIbCJ

❣️ Elevate Patient Care with CSHP and @CCPNrx! Gain the tools and insights to deliver exceptional care for patients with ASCVD at the Canadian Pharmacy Atherosclerotic Cardiovascular Disease Symposium. 🎟️: https://t.co/YM4QIqqp3z

@wbaker0531 @accpcardprn …another 🪵 on the 🔥

More data supporting the role of pharmacists in HF and associated conditions. @accpcardprn

Watch our updated top 15 outpatient drug purchases in 🇨🇦 From our updated forecast paper! https://t.co/dlqQu64gQN

The recording of our December #webinar is now online! ⏯️ Hear from Dr. David Gardner about the current best practice for #insomnia care and explore resources to support your patients: https://t.co/kE1zz5n6uF

When it comes to the Christmas season in French Canada, one dish that is always loved is Tourtière. It is a delicious dish, and its history dates back to the earliest days of New France. Let's learn more about the history of Tourtière :) 🧵1/8

Going to #AHA24? Come talk to @BlairMacPharmD about our latest modeling study of pharmacotherapy for heart failure with reduced ejection fraction, this time looking at 1-year efficacy/safety of different quadruple therapy sequencing strategies:

Join us virtually at the 23rd Annual CCPN Western Symposium on Saturday, November 23! Agenda at https://t.co/XPxQMqzmc8 Register now!

If you liked yesterday's @CMAJ paper on heart failure sequencing strategies, wait until you see what @BlairMacPharmD's cooking up next as part of his CIHR HSI fellowship - 'Evaluation of Models of Care for HFrEF Through the Use of a Microsimulation Model'

The new cohort of the Health System Impact Fellowship is here! 🎉 45 talented researchers will work with 35 health organizations nationwide to drive innovation and tackle Canada's most pressing health issues. https://t.co/1gkIfi4FAt #CIHR_ImpactFellows